CIK 0001668243
- Non-accelerated filer
- Smaller reporting company
UroGen Pharma Ltd.
Sign in to watch- Ticker
- URGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- Phone
- +972 97707601
- Business address
- 9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $182,793
- in 3 filings
Net −$182,793. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 8 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-01-31 | PFREUNDSCHUH PETER P. Chief Financial Officer | Grant or award · Restricted Stock Unit | +6,000 | 6,000 | ||
| 2020-01-31 | Mullennix Stephen Chief Operating Officer | Grant or award · Stock options (right to buy) | +15,000 | 15,000 | ||
| 2020-01-31 | Mullennix Stephen Chief Operating Officer | Grant or award · Restricted stock unit | +3,000 | 3,000 | ||
| 2020-01-31 | Schoenberg Mark Chief Medical Officer | Grant or award · Stock options (right to buy) | +15,000 | 15,000 | ||
| 2020-01-31 | Schoenberg Mark Chief Medical Officer | Grant or award · Restricted stock unit | +6,000 | 6,000 | ||
| 2020-01-31 | Barrett Elizabeth A. Chief Executive Officer | Grant or award · Stock options (right to buy) | +45,000 | 45,000 | ||
| 2020-01-31 | Barrett Elizabeth A. Chief Executive Officer | Grant or award · Restricted Stock Unit | +15,000 | 15,000 | ||
| 2020-01-27 | PFREUNDSCHUH PETER P. Chief Financial Officer | Sale | −667 | $29.28 | $20K | 4,438 |
| 2020-01-27 | Mullennix Stephen Chief Operating Officer | Sale | −684 | $29.26 | $20K | 8,665 |
| 2020-01-27 | Schoenberg Mark Chief Medical Officer | Sale | −322 | $29.15 | $9K | 9,177 |
| 2020-01-26 | PFREUNDSCHUH PETER P. Chief Financial Officer | Exercise or conversion | +1,666 | 5,105 | ||
| 2020-01-26 | PFREUNDSCHUH PETER P. Chief Financial Officer | Exercise or conversion · Restricted Stock Units (RSUs) | −1,666 | 3,334 | ||
| 2020-01-26 | Mullennix Stephen Chief Operating Officer | Exercise or conversion | +1,666 | 9,349 | ||
| 2020-01-26 | Mullennix Stephen Chief Operating Officer | Exercise or conversion · Restricted Stock Units (RSUs) | −1,666 | 3,334 | ||
| 2020-01-26 | Schoenberg Mark Chief Medical Officer | Exercise or conversion | +833 | 9,499 | ||
| 2020-01-26 | Schoenberg Mark Chief Medical Officer | Exercise or conversion · Restricted Stock Units (RSUs) | −833 | 1,667 | ||
| 2020-01-03 | Barrett Elizabeth A. Chief Executive Officer | Exercise or conversion | +105,688 | 122,236 | ||
| 2020-01-03 | Barrett Elizabeth A. Chief Executive Officer | Exercise or conversion · Ordinary Shares | −105,688 | 211,377 | ||
| 2019-12-04 | Schoenberg Mark Chief Medical Officer | Exercise or conversion | +1,042 | 9,009 | ||
| 2019-12-04 | Schoenberg Mark Chief Medical Officer | Shares withheld for taxes | −343 | $31.69 | $11K | 8,666 |
Page 23 of 25 · 496 trades